Metraipolis › archive › dc_fc553761643d
Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42719185
- DOI
- 10.3389/fphar.2026.1844013
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T19:05:09.268Z
- SHA-256 of the archived text
53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516- Stable URL of this page
https://metraipolis.com/documento/dc_fc553761643d
How to cite
Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185 — Europe PMC (en), https://europepmc.org/article/MED/42719185 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc553761643d (Metraipolis archive dc_fc553761643d, sha256 53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516)
BibTeX
@misc{dcfc553761643d,
title = {Trastuzumab-TKI combination in HER2-Positive tumors: a FAERS-Based safety profile and multimodal analysis of Tanespimycin's role in enhancing targeting of the… — Europe PMC PMID:42719185},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42719185},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc553761643d; sha256 53dae62eb7f4cb3b4f8bba6be51996e21ff6eb9e04d24e0ebb721c6b0eb1e516},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42719185. Agents can read the archived copy with the MCP tool read_document.